Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma - Related Studies

Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma

This study is ongoing, but not recruiting participants.

Study NCT00077155. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Lymphoma

2	Additional conditions recognized in this trial
		Lymphoma, Non-Hodgkin

3	More general conditions related to this trial
		Immune System Diseases
		Immunoproliferative Disorders
		Lymphatic Diseases
		Lymphoproliferative Disorders
		Neoplasms
		Neoplasms by Histologic Type

4	Interventions listed in this trial
		cilengitide

5	Sponsors listed in this trial
		University of Chicago
		National Cancer Institute (NCI)